Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

ALK

Alkemy Capital Investments (ALK)

Alkemy Capital Investments Plc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:ALK
DataHoraFonteTítuloCódigoCompanhia
26/02/202404:00RNS Regulatory NewsAlkemy Capital Investments PLC Change of AdviserLSE:ALKAlkemy Capital Investments Plc
30/01/202411:20Alliance NewsAlliance NewsTRADING UPDATES: Lexington completes Bothaville drilling phaseLSE:ALKAlkemy Capital Investments Plc
30/01/202404:00RNS Regulatory NewsAlkemy Capital Investments PLC MOU with Syrah for UK’s first Graphite refineryLSE:ALKAlkemy Capital Investments Plc
18/01/202411:34UK Regulatory0OIR Alk Afslutter Første Del Af Fase 1-studie Med PeanuttabletLSE:ALKAlkemy Capital Investments Plc
18/01/202411:34UK Regulatory0OIR Alk Completes First Part Of Phase 1 Trial With Peanut Slit-tabletLSE:ALKAlkemy Capital Investments Plc
18/01/202411:28Alliance NewsAlliance NewsIN BRIEF: Alkemy Capital optimistic on lithium process outlookLSE:ALKAlkemy Capital Investments Plc
18/01/202404:00UK RegulatoryAlkemy Capital Investments PLC Corporate UpdateLSE:ALKAlkemy Capital Investments Plc
04/01/202410:00UK Regulatory0OIR Alk To Become Sole Manufacturer And Distributor Of Skin Antigen Test For Penicillin AllergyLSE:ALKAlkemy Capital Investments Plc
02/01/202414:00UK RegulatoryAlkemy Capital Investments PLC Correction - Oversubscribed PlacingLSE:ALKAlkemy Capital Investments Plc
20/12/202306:45UK Regulatory0OIR Alk -- Finanskalender For Regnskabsåret 2024LSE:ALKAlkemy Capital Investments Plc
20/12/202306:45UK Regulatory0OIR Alk -- Financial Calendar For The 2024 Financial YearLSE:ALKAlkemy Capital Investments Plc
18/12/202312:59Alliance NewsAlliance NewsIN BRIEF: Alkemy Capital raises GBP650,000 in oversubscribed placingLSE:ALKAlkemy Capital Investments Plc
18/12/202304:00UK RegulatoryAlkemy Capital Investments PLC Oversubscribed Placing to raise GBP650,000LSE:ALKAlkemy Capital Investments Plc
12/12/202312:08UK Regulatory0OIR Alk Expands Partnership With Torii In JapanLSE:ALKAlkemy Capital Investments Plc
12/12/202312:08UK Regulatory0OIR Alk Udvider Partnerskab Med Torii I JapanLSE:ALKAlkemy Capital Investments Plc
04/12/202309:03Alliance NewsAlliance NewsAlkemy Capital subsidiary secures partnerships for lithium refineryLSE:ALKAlkemy Capital Investments Plc
04/12/202304:00UK RegulatoryAlkemy Capital Investments PLC TVL Secures Technology and Vendor PartnershipsLSE:ALKAlkemy Capital Investments Plc
20/11/202304:00UK RegulatoryAlkemy Capital Investments PLC Appointment of Battery Metals Supply Chain ExpertLSE:ALKAlkemy Capital Investments Plc
15/11/202303:30UK Regulatory0OIR Nine-month Interim Report (Q3) 2023LSE:ALKAlkemy Capital Investments Plc
13/11/202318:58Alliance NewsAlliance NewsTRADING UPDATES: 88 Energy signs farm-in deal with Monitor ExplorationLSE:ALKAlkemy Capital Investments Plc
13/11/202304:00UK RegulatoryAlkemy Capital Investments PLC TVL First Feedstock DealLSE:ALKAlkemy Capital Investments Plc
09/11/202309:46UK Regulatory0OIR Dato For Offentliggørelse Af Delårsrapport For Første Ni Måneder (Q3) 2023 For Alk Og WebcastLSE:ALKAlkemy Capital Investments Plc
09/11/202309:46UK Regulatory0OIR Release Date Of Nine-month Interim Report (Q3) 2023 For Alk And Audio CastLSE:ALKAlkemy Capital Investments Plc
01/11/202308:20UK RegulatoryAlkemy Capital Investments PLC Corporate PresentationLSE:ALKAlkemy Capital Investments Plc
31/10/202308:00RNS Non-RegulatoryAlkemy Capital Investments PLC Investor WebinarLSE:ALKAlkemy Capital Investments Plc
27/10/202317:39Alliance NewsAlliance NewsIN BRIEF: Alkemy narrows loss, supplier and customer talks continueLSE:ALKAlkemy Capital Investments Plc
27/10/202304:00UK RegulatoryAlkemy Capital Investments PLC Interim Results for Period Ended 31 July 2023LSE:ALKAlkemy Capital Investments Plc
24/10/202303:05UK RegulatoryAlkemy Capital Investments PLC VSA lifts target price to GBP15.30 per shareLSE:ALKAlkemy Capital Investments Plc
11/10/202311:13UK Regulatory0OIR Large Phase 3 Clinical Trial Successfully Meets Primary Endpoint, Confirming The Potential Of Alk's Tree Tablet In ChildrenLSE:ALKAlkemy Capital Investments Plc
11/10/202311:13UK Regulatory0OIR Stort Klinisk Fase 3-studie Når Sit Primære Endemål Og Bekræfter Potentialet Af Alk's Tabletvaccine Mod Træpollenallergi Til BørnLSE:ALKAlkemy Capital Investments Plc
 Apresentando as notícias mais relevantes sobre:LSE:ALK